Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/EPRX stock hub

TSX/EPRX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/EPRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

634.1M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/EPRX

In the news

Latest news · TSX/EPRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-68.8

P25 -121.5P50 -40.9P75 0.5

ROIC-42.7

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/EPRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

USD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	49
Employees Change	16%
Employees Change Percent	48.48
Enterprise value	CAD 562.4M
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA29842P1053
Last refreshed	2026-05-10
Market cap	CAD 634.1M
Price	CAD 10.31
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsx/EPRX
Website	https://www.eupraxiapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.89%
EV Earnings	-9.98x
EV/FCF	-14.08x
FCF yield	-6.3%
P/B ratio	5.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -56.4M
Net Income Growth Years	0%
Profit Per Employee	CAD -1.2M
ROA	-39.67
Roa5y	-61.98
ROCE	-47.73
ROE	-68.76
ROIC	-42.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	93.89%
Cagr3y	18.98%
Cagr5y	17.32%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 118.1M
Cash	CAD 110.5M
Current Assets	CAD 116.3M
Current Liabilities	CAD 7.7M
Debt	CAD 211,649
Debt Equity	CAD 0
Debt FCF	CAD -0.01
Equity	CAD 110.3M
Liabilities	CAD 7.8M
Long Term Assets	CAD 1.8M
Long Term Liabilities	CAD 126,988
Net Cash	CAD 110.3M
Net Cash By Market Cap	CAD 17.39
Net Cash Growth	143.45%
Net Debt Equity	CAD -1
Tangible Book Value	CAD 71.7M
Tangible Book Value Per Share	CAD 1.38
WACC	12.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.12
Net Working Capital	CAD -1.4M
Quick ratio	14.43
Working Capital	CAD 109M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	93.8%
200-day SMA	9.29
3Y total return	68.46%
50-day SMA	10.13
50-day SMA vs 200-day SMA	50over200
5Y total return	122.2%
All Time High	12.86
All Time High Change	-19.83%
All Time High Date	2026-01-21
All Time Low	0.8
All Time Low Change	1,188.75%
All Time Low Date	2022-05-10
ATR	0.54
Beta	1.42
Beta1y	0.91
Beta2y	0.95
Ch YTD	-0.1
High	10.42
High52	12.86
High52 Date	2026-01-21
High52ch	-19.83%
Low	9.98
Low52	5.01
Low52 Date	2025-05-23
Low52ch	105.79%
Ma50ch	1.82%
Price vs 200-day SMA	10.98%
RSI	53.35
RSI Monthly	65.07
RSI Weekly	54.57
Sharpe ratio	1.39x
Sortino ratio	2.58
Total Return	-17.76%
Tr YTD	-0.1
Tr1m	9.33%
Tr1w	-4.09%
Tr3m	-10.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -52.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,485,188%
Shares Insiders	18.37%
Shares Institutions	25.08%
Shares Out	61,503,180
Shares Qo Q	38.96%
Shares Yo Y	17.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -52M
Average Volume	45,854.15x
Bv Per Share	1.38
CAPEX	CAD -807,517
Ch1m	9.33
Ch1w	-4.09
Ch1y	93.8
Ch3m	-10.03
Ch3y	68.46
Ch5y	122.2
Ch6m	34.25
Change	0.59%
Change From Open	0.78
Close	10.25
Days Gap	-0.2
Depreciation Amortization	224,748.5
Dollar Volume	522,985.1
Earnings Date	2026-05-15
EBIT	CAD -52.7M
EBITDA	CAD -52.5M
EPS	CAD -1.41
F Score	2
FCF	CAD -40M
FCF EV Yield	-7.1x
FCF Per Share	CAD -0.65
Financing CF	104,285,385
Fiscal Year End	December
Founded	2,011
Income Tax	CAD 26,176
Investing CF	-807,517
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Ma150	9.87
Ma150ch	4.48%
Ma20	10.03
Ma20ch	2.76%
Net CF	65,076,355
Next Earnings Date	2026-05-15
Open	10.23
Position In Range	75
Ppne	1,349,450.6
Price Date	2026-05-08
Ptbv Ratio	8.84
Relative Volume	1.14x
Share Based Comp	12,005,673
Tr6m	34.25%
Volume	50,726

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/EPRX pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/EPRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/EPRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.1%

Share of float held by funds and institutions

Insider ownership

+18.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+17.8%

Negative means the company is buying back shares.

Technical

TSX/EPRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.3

Neutral momentum band

Price vs 200-day MA

+11.0%

50/200-day relationship not available

Beta (5Y)

1.42

More volatile than the market

Sharpe ratio

1.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/EPRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/EPRX stock rating?

tsx/EPRX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/EPRX analysis?

The full report lives at /stocks/tsx/EPRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/EPRX?

The latest report frames tsx/EPRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/EPRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.